117 related articles for article (PubMed ID: 2559710)
41. [Relation between female genital human papilloma virus (HPV) infection and cancer of uterine cervix in Xiang Yuan County, a high incidence area of cervical carcinoma].
Wu AR
Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):293-6. PubMed ID: 1327703
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
43. HPV DNA and the risk of squamous intraepithelial lesions of the uterine cervix in young women.
Levine AJ; Harper J; Hilborne L; Rosenthal DL; Weismeier E; Haile RW
Am J Clin Pathol; 1993 Jul; 100(1):6-11. PubMed ID: 8394050
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
45. Pills, partners and preventive prospects: in-situ cancer of the cervix.
McMichael AJ; Hiller JE
Med J Aust; 1989 Feb; 150(3):114-6. PubMed ID: 2541323
[TBL] [Abstract][Full Text] [Related]
46. Contraceptive and reproductive risks for cervical dysplasia in southwestern Hispanic and non-Hispanic white women.
Becker TM; Wheeler CM; McGough NS; Stidley CA; Parmenter CA; Dorin MH; Jordan SW
Int J Epidemiol; 1994 Oct; 23(5):913-22. PubMed ID: 7860171
[TBL] [Abstract][Full Text] [Related]
47. Frequency of cervico-vaginal infections (Trichomonas vaginalis; Chlamydia trachomatis -CHL-; herpes simplex virus -HSV-; human papilloma virus -HPV-) in cervical intraepithelial neoplasia.
Alberico S; Facca MC; Di Bonito L; Millo R; Casaccia R; Mandruzzato GP
Eur J Gynaecol Oncol; 1988; 9(3):252-7. PubMed ID: 2839342
[TBL] [Abstract][Full Text] [Related]
48. Cervical dysplasia and cancer and the use of hormonal contraceptives in Jamaican women.
McFarlane-Anderson N; Bazuaye PE; Jackson MD; Smikle M; Fletcher HM
BMC Womens Health; 2008 May; 8():9. PubMed ID: 18513406
[TBL] [Abstract][Full Text] [Related]
49. Epidemiology of genital papillomaviruses and cervical cancer.
Reeves WC; Rawls WE; Brinton LA
Rev Infect Dis; 1989; 11(3):426-39. PubMed ID: 2546242
[TBL] [Abstract][Full Text] [Related]
50. Human papillomaviruses, cervical cancer and the developing world.
Birley HD
Ann Trop Med Parasitol; 1995 Oct; 89(5):453-63. PubMed ID: 7495358
[TBL] [Abstract][Full Text] [Related]
51. The histopathology of biopsies taken from women attending a New Zealand colposcopy clinic.
Chang AR
Pathology; 1991 Apr; 23(2):90-3. PubMed ID: 1660592
[TBL] [Abstract][Full Text] [Related]
52. Evidence for practice: oral contraception and risk of cervical cancer.
Bertram CC
J Am Acad Nurse Pract; 2004 Oct; 16(10):455-61. PubMed ID: 15543923
[TBL] [Abstract][Full Text] [Related]
53. Human papillomavirus infection and use of oral contraceptives.
Green J; Berrington de Gonzalez A; Smith JS; Franceschi S; Appleby P; Plummer M; Beral V
Br J Cancer; 2003 Jun; 88(11):1713-20. PubMed ID: 12771986
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic problems of cervico-vaginal infections by HPV.
Minucci D; Torrisi A; Zambon C; Salviato MG
Eur J Gynaecol Oncol; 1987; 8(2):122-6. PubMed ID: 3032635
[TBL] [Abstract][Full Text] [Related]
55. Association between Hormonal Contraception and Injuries Induced by Human Papillomavirus in the Uterine Cervix.
Volpato LK; Siqueira IR; Nunes RD; Piovezan AP
Rev Bras Ginecol Obstet; 2018 Apr; 40(4):196-202. PubMed ID: 29702717
[TBL] [Abstract][Full Text] [Related]
56. Nutrition and cervical neoplasia.
Potischman N; Brinton LA
Cancer Causes Control; 1996 Jan; 7(1):113-26. PubMed ID: 8850440
[TBL] [Abstract][Full Text] [Related]
57. Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa).
Shapiro S; Rosenberg L; Hoffman M; Kelly JP; Cooper DD; Carrara H; Denny LE; du Toit G; Allan BR; Stander IA; Williamson AL
Cancer Causes Control; 2003 Jun; 14(5):485-95. PubMed ID: 12946044
[TBL] [Abstract][Full Text] [Related]
58. Estro-progestin Contraceptives and Risk of Cervical Cancer: A Debated Issue.
Gadducci A; Cosio S; Fruzzetti F
Anticancer Res; 2020 Nov; 40(11):5995-6002. PubMed ID: 33109537
[TBL] [Abstract][Full Text] [Related]
59. The epidemiology of cervical cancer.
Franco EL; Schlecht NF; Saslow D
Cancer J; 2003; 9(5):348-59. PubMed ID: 14690309
[TBL] [Abstract][Full Text] [Related]
60. Cervical cancer precursors and hormonal contraceptive use in HIV-positive women: application of a causal model and semi-parametric estimation methods.
Leslie HH; Karasek DA; Harris LF; Chang E; Abdulrahim N; Maloba M; Huchko MJ
PLoS One; 2014; 9(6):e101090. PubMed ID: 24979709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
